HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization and proteolytic origins of specific peptides appearing during lipopolysaccharide experimental mastitis.

Abstract
Based on the compositional change of the proteose peptone fraction, proteolysis was studied over time following lipopolysaccharide-induced experimental mastitis. Electrophoresis of the proteose peptone fraction revealed many degradation products. Five peptides were identified by amino-terminal sequencing as internal fragments of beta-, kappa-, alpha(s1)-, and alpha(s2)-casein that were generated by somatic cell proteases. Although kappa-casein is considered particularly resistant to endogenous proteolysis, a kappa-casein peptide was electrophoretically isolated in association with a beta-casein fragment. The in vitro kinetic studies of caseinate hydrolysis by elastase, one of the main polymorphonuclear neutrophil (PMN) proteases, suggested that the beta-casein peptide might be generated by elastase. In addition, elastase activity in milk PMN was higher during the inflammation of the mammary gland than prior to infusion.
AuthorsF Moussaoui, F Laurent, J M Girardet, G Humbert, J L Gaillard, Y Le Roux
JournalJournal of dairy science (J Dairy Sci) Vol. 86 Issue 4 Pg. 1163-70 (Apr 2003) ISSN: 0022-0302 [Print] United States
PMID12741540 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Caseins
  • Lipopolysaccharides
  • Peptide Fragments
  • Endopeptidases
  • Leukocyte Elastase
Topics
  • Amino Acid Sequence
  • Animals
  • Caseins (chemistry, metabolism)
  • Cattle
  • Endopeptidases (metabolism)
  • Escherichia coli
  • Female
  • Hydrolysis
  • Leukocyte Elastase (metabolism)
  • Lipopolysaccharides (administration & dosage)
  • Mastitis, Bovine (chemically induced, metabolism)
  • Milk (cytology, enzymology)
  • Molecular Sequence Data
  • Neutrophils (enzymology)
  • Peptide Fragments (analysis, chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: